Zobrazeno 1 - 10
of 21
pro vyhledávání: '"P L, Kirichenko"'
Autor:
L. L. Kirichenko, S. V. Gatsura, A. N. Golosova, Zh. Yu. Dvoryanchikova, E. A. Ulyanova, K. M. Chuprikova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 15, Iss 6, Pp 83-88 (2016)
Arterial hypertension (AH) is a serious medical and social problem due to its complications leading to disability. Recently, there is a lot of attention paid to markers evaluation for cardiovascular pathology — endothelial dysfunction, arteries ela
Externí odkaz:
https://doaj.org/article/1af89fd1d0dd4af39e87f6470c694ca9
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 2, Pp 166-169 (2015)
Aim. To assess the effectiveness of educational programs in the treatment of patients with metabolic syndrome (MS).Material and methods. Patients with MS (n=68) were randomized into two groups of 34 people. Patients of the first group received standa
Externí odkaz:
https://doaj.org/article/33b19787928145f7a3cbf11d09bbb190
Autor:
L. L. Kirichenko, S. V. Gatsura, A. N. Golosova, K. V. Ovsyannikov, O. V. Budik, A. V. Fedorov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 13, Iss 1, Pp 64-68 (2014)
The paper focuses on the justification for preferential administration of antihypertensive combination therapy. Pharmacotherapeutic features of starting the treatment with a combination of angiotensin-converting enzyme inhibitors (ACEI) and calcium a
Externí odkaz:
https://doaj.org/article/a8df74686148437dbd8d8840f940029b
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 12, Iss 5, Pp 45-48 (2013)
Recently, the clinicians’ attention has been driven to metabolic syndrome (MS), due to increasing prevalence and adverse prognosis of MS. The goal of the treatment of any chronic disease is the achievement of adequate therapeutic compliance which,
Externí odkaz:
https://doaj.org/article/a06091a3be124862bdf7f0467178687b
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 11, Iss 2, Pp 85-89 (2012)
Metabolic syndrome (MS) has recently gained more clinical attention due to its increasing prevalence and association with adverse prognosis. One of the main pathological features of MS is endothelial dysfunction. It plays a key role in the developmen
Externí odkaz:
https://doaj.org/article/0ea10260879c48e4959c71e07783c14e
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 3, Pp 9-14 (2011)
Aim. To identify the criteria of early left ventricular (LV) remodelling; to assess the baseline structure and function of left and right cardiac chambers, as well as their dynamics during adequate antihypertensive therapy (AHT), in patients with Sta
Externí odkaz:
https://doaj.org/article/f820a7b5b69347779550157305e33777
Autor:
L. L. Kirichenko, A. N. Golosova, S. V. Gatsura, A. P. Korolev, P. P. Struchkov, Zh. D. Dvoryanchikova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 7, Iss 2, Pp 109-116 (2008)
This literature review is analyzing heart rate (HR) role in the pathogenesis of arterial hypertension (AH) and coronary heart disease (CHD), together with HR prognostic role in assessing cardiovascular event risk. Modern approaches to pharmaceutical
Externí odkaz:
https://doaj.org/article/09ca0514f3db46ae9413dac5b54ce0e0
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 6, Iss 6, Pp 103-108 (2007)
Arterial hypertension (AH) is one of the most prevalent diseases. Despite impressive progress in studying AH pathogenesis, treatment results should still be improved. It is mostly explained by poor therapy compliance in patients taking antihypertensi
Externí odkaz:
https://doaj.org/article/f7c1dc44b7214ddd81bacbd8409eafd4
Autor:
A. P. Sharandak, L. L. Kirichenko, Zh. Yu. Dvoryanchikova, O. S. Tseka, A. P. Korolev, M. V. Koroleva, E. T. Lilyin
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 6, Iss 1, Pp 23-27 (2007)
Aim. Using twin models, to demonstrate the leading role of environmental factors for blood pressure (BP) variability (Var) and circadian rhythm (CR) parameters. Material and methods. In total, 74 twin pairs with normal BP (mean age 42,4±2,3 years) a
Externí odkaz:
https://doaj.org/article/146d3d06614d4171b4768a390566b27b
Autor:
L. L. Kirichenko, O. V. Vostryakova, Yu. A. Babich, N. V. Burlyay, Zh. I. Vasheva, A. P. Korolev, O. B. Golovkova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 5, Iss 6, Pp 27-31 (2006)
Aim. To compare microcirculation (MC) functional status during the treatment with beta-adrenoblockers (BAB), with and without vasodilatatory effects, in patients with Stage I-II arterial hypertension (AH). Material and methods. In total, 61 Stage I-I
Externí odkaz:
https://doaj.org/article/c46431e732794ab49d60a8a6b8769776